<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01601704</url>
  </required_header>
  <id_info>
    <org_study_id>NB-CVOT</org_study_id>
    <secondary_id>The Light Study</secondary_id>
    <secondary_id>U1111-1162-4981</secondary_id>
    <nct_id>NCT01601704</nct_id>
  </id_info>
  <brief_title>Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)</brief_title>
  <official_title>A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Assessing the Occurrence of Major Adverse Cardiovascular Events (MACE) in Overweight and Obese Subjects With Cardiovascular Risk Factors Receiving Naltrexone SR/Bupropion SR</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Orexigen Therapeutics, Inc</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Orexigen Therapeutics, Inc</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the effects of NB relative to placebo on major
      adverse cardiovascular events (MACE) such as cardiovascular death, non-fatal myocardial
      infarction, and non-fatal stroke in overweight and obese subjects who are at a higher risk of
      having these events because they have diabetes and/or other cardiovascular risk factors.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <start_date>June 2012</start_date>
  <completion_date type="Actual">August 2015</completion_date>
  <primary_completion_date type="Actual">August 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of Participants With a Confirmed Occurrence of Major Adverse Cardiovascular Event (MACE)</measure>
    <time_frame>Confirmed occurrence of event between Day 1 (randomization) and up to a maximum of 4 years of follow-up</time_frame>
    <description>The primary endpoint is the time from randomization to the first confirmed occurrence of any event within the primary MACE composite (defined as cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke). Due to early termination of the study, pre-planned 50% interim analysis is considered the primary analysis for outcome measures. The pre-planned 50% interim analysis was conducted when 50% of the total planned MACE were observed.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants With a Confirmed Occurrence of Cardiovascular Death, Nonfatal Myocardial Infarction, Nonfatal Stroke, or Nonfatal Unstable Angina Requiring Hospitalization</measure>
    <time_frame>Confirmed occurrence of event between Day 1 (randomization) and up to a maximum of 4 years of follow-up</time_frame>
    <description>Due to early termination of the study, the pre-planned 50% interim analysis is considered the primary analysis for outcome measures.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants With a Confirmed Occurrence of Cardiovascular Death (Including Fatal Myocardial Infarction, Fatal Stroke)</measure>
    <time_frame>Confirmed occurrence of event between Day 1 (randomization) and up to a maximum of 4 years of follow-up</time_frame>
    <description>Due to early termination of the study, the pre-planned 50% interim analysis is considered the primary analysis for outcome measures.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants With a Confirmed Occurrence of Myocardial Infarction (Nonfatal or Fatal)</measure>
    <time_frame>Confirmed occurrence of event between Day 1 (randomization) and up to a maximum of 4 years of follow-up</time_frame>
    <description>Due to early termination of the study, the pre-planned 50% interim analysis is considered the primary analysis for outcome measures.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants With a Confirmed Occurrence of Stroke (Nonfatal or Fatal)</measure>
    <time_frame>Confirmed occurrence of event between Day 1 (randomization) and up to a maximum of 4 years of follow-up</time_frame>
    <description>Due to early termination of the study, the pre-planned 50% interim analysis is considered the primary analysis for outcome measures.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">8910</enrollment>
  <condition>Obesity</condition>
  <condition>Overweight</condition>
  <arm_group>
    <arm_group_label>NB32</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>PBO</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>NB32</intervention_name>
    <description>Naltrexone SR 32 mg/Bupropion SR 360 mg/day. Administered in addition to the weight management program.</description>
    <arm_group_label>NB32</arm_group_label>
    <other_name>CONTRAVE</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>PBO</intervention_name>
    <description>Placebo. Administered in addition to the weight management program.</description>
    <arm_group_label>PBO</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Weight Management Program</intervention_name>
    <description>A comprehensive weight management program will be administered in addition to the subject's study medication assignment. The program includes internet counseling by an accredited health and fitness professional and a nutrition and exercise program with goal setting and educational and tracking tools.</description>
    <arm_group_label>NB32</arm_group_label>
    <arm_group_label>PBO</arm_group_label>
    <other_name>WeightMate (Tm)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. ≥50 years of age (women) or ≥45 years of age (men)

          2. Body mass index (BMI) ≥27 kg/m2 and ≤50 kg/m2

          3. Waist circumference ≥88 cm (women) or ≥102 cm (men)

          4. At increased risk of adverse cardiovascular outcomes:

               -  Cardiovascular disease (confirmed diagnosis or at high likelihood of
                  cardiovascular disease) with at least one of the following:

                    -  History of documented myocardial infarction &gt;3 months prior to screening

                    -  History of coronary revascularization

                    -  History of carotid or peripheral revascularization

                    -  Angina with ischemic changes (resting ECG), ECG changes on a graded exercise
                       test (GXT), or positive cardiac imaging study

                    -  Ankle brachial index &lt;0.9 (by simple palpation) within prior 2 years

                    -  ≥50% stenosis of a coronary, carotid, or lower extremity artery within prior
                       2 years

        AND/OR

          -  Type 2 diabetes mellitus with at least 2 of the following:

               -  Hypertension (controlled with or without pharmacotherapy at &lt;145/95 mm Hg)

               -  Dyslipidemia requiring pharmacotherapy

               -  Documented low HDL cholesterol (&lt;50 mg/dL in women or &lt;40 mg/dL in men) within
                  prior 12 months

               -  Current tobacco smoker

        Exclusion Criteria:

          1. Myocardial infarction within 3 months prior to screening

          2. Angina pectoris Grade III or IV as per the Canadian Cardiovascular Society grading
             scheme

          3. Clinical history of cerebrovascular disease (stroke)

          4. History of tachyarrhythmia other than sinus tachycardia

          5. Planned bariatric surgery, cardiac surgery, or coronary angioplasty

          6. History of seizures (including febrile seizures), cranial trauma, or other conditions
             that predispose the subject to seizures

          7. History of mania or current diagnosis of active psychosis, active bulimia or anorexia
             nervosa (binge eating disorder is not exclusionary)

          8. Any condition with life expectancy anticipated to be less than 4 years (e.g.,
             congestive heart failure NYHA Class 3 or 4)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Medical Director Clinical Science</last_name>
    <role>Study Director</role>
    <affiliation>Takeda</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Dothan</city>
        <state>Alabama</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mobile</city>
        <state>Alabama</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Scottsboro</city>
        <state>Alabama</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Chandler</city>
        <state>Arizona</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mesa</city>
        <state>Arizona</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Peoria</city>
        <state>Arizona</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tuscson</city>
        <state>Arizona</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Anaheim</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Carmichael</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Escondido</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Fresno</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Harbor City</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Huntington Beach</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lomita</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Paramount</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pasadena</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Riverside</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Santa Rosa</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Spring Valley</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Thousand Oaks</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Torrance</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>West Hills</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Colorado Springs</city>
        <state>Colorado</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Golden</city>
        <state>Colorado</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wheat Ridge</city>
        <state>Colorado</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Norwalk</city>
        <state>Connecticut</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Stamford</city>
        <state>Connecticut</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wilmington</city>
        <state>Delaware</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Boynton Beach</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Brooksville</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Clearwater</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Deland</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Delray Beach</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Jacksonville Beach</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Melbourne</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>New Port Richey</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>New Smyrna Beach</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Oakland Park</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Palm Harbor</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pembroke Pines</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pensacola</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pinellas Park</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Saint Petersburg</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Vero beach</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wellington</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Winter Haven</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Austell</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Columbus</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lawrenceville</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Riverdale</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Savannah</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Stockbridge</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Meridian</city>
        <state>Idaho</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Gurnee</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Melrose Park</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bloomington</city>
        <state>Indiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Brownsburg</city>
        <state>Indiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Elwood</city>
        <state>Indiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Evansville</city>
        <state>Indiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hammond</city>
        <state>Indiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>South Bend</city>
        <state>Indiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Valparaiso</city>
        <state>Indiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ames</city>
        <state>Iowa</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Council Bluffs</city>
        <state>Iowa</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Des Moines</city>
        <state>Iowa</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>West Des Moines</city>
        <state>Iowa</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Overland Park</city>
        <state>Kansas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Crestview Hills</city>
        <state>Kentucky</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mount Sterling</city>
        <state>Kentucky</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Alexandria</city>
        <state>Louisiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Baton Rouge</city>
        <state>Louisiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Monroe</city>
        <state>Louisiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Natchitoches</city>
        <state>Louisiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Auburn</city>
        <state>Maine</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bangor</city>
        <state>Maine</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Columbia</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Elkridge</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lutherville</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Salisbury</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Brockton</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Fall River</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Haverhill</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Methuen</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bingham Farms</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Dearbon</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kalamazoo</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Midland</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Saginaw</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Southfield</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Stevensville</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Edina</city>
        <state>Minnesota</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Jackson</city>
        <state>Mississippi</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Olive Branch</city>
        <state>Mississippi</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tupelo</city>
        <state>Mississippi</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Butte</city>
        <state>Montana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Missoula</city>
        <state>Montana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Fremont</city>
        <state>Nebraska</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Grand Island</city>
        <state>Nebraska</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Henderson</city>
        <state>Nevada</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Reno</city>
        <state>Nevada</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sparks</city>
        <state>Nevada</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Belvidere</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Edison</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Elizabeth</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Elmer</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Linden</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ridgewood</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Endwell</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>New Hyde Park</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>New York</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Staten Island</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Williamsville</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cary</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Elizabeth City</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Greensboro</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Greenville</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hickory</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Morganton</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Salisbury</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wilmington</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Akron</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Beachwood</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Delaware</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kettering</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Marion</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mentor</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Willoughby Hills</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Medford</city>
        <state>Oregon</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Altoona</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bensalem</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Danville</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Duncansville</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ephrata</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Jersey Shore</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lancaster</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lansdale</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Norristown</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Scottdale</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sellersville</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>State College</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>West Reading</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wilkes-Barre</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Anderson</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Columbia</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Greer</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hodges</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Laurens</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mount Pleasant</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Rapid City</city>
        <state>South Dakota</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bristol</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Chattanooga</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Germantown</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Jackson</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kingsport</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Knoxville</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Beaumont</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Corpus Christi</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hurst</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lake Jackson</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>McKinney</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Schertz</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tomball</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Waco</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bountiful</city>
        <state>Utah</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Draper</city>
        <state>Utah</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Murray</city>
        <state>Utah</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ogden</city>
        <state>Utah</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Orem</city>
        <state>Utah</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>West Jordan</city>
        <state>Utah</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Alexandria</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Winchester</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tacoma</city>
        <state>Washington</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Walla Walla</city>
        <state>Washington</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Green Bay</city>
        <state>Wisconsin</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kenosha</city>
        <state>Wisconsin</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 14, 2012</study_first_submitted>
  <study_first_submitted_qc>May 16, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 18, 2012</study_first_posted>
  <results_first_submitted>December 11, 2016</results_first_submitted>
  <results_first_submitted_qc>February 24, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">February 27, 2017</results_first_posted>
  <last_update_submitted>February 24, 2017</last_update_submitted>
  <last_update_submitted_qc>February 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Body Weight</keyword>
  <keyword>Bupropion</keyword>
  <keyword>Cardiovascular Diseases</keyword>
  <keyword>Diabetes Mellitus</keyword>
  <keyword>Diabetes Mellitus, Type 2</keyword>
  <keyword>Endocrine System Diseases</keyword>
  <keyword>Glucose Metabolism Disorders</keyword>
  <keyword>Heart Diseases</keyword>
  <keyword>Metabolic Diseases</keyword>
  <keyword>Narcotic Antagonists</keyword>
  <keyword>Naltrexone</keyword>
  <keyword>Nutrition Disorders</keyword>
  <keyword>Obesity</keyword>
  <keyword>Overnutrition</keyword>
  <keyword>Overweight</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Naltrexone</mesh_term>
    <mesh_term>Bupropion</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>NB32</title>
          <description>NB32: Naltrexone SR 32 mg/Bupropion SR 360 mg/day. Administered in addition to the weight management program.
Weight Management Program: A comprehensive weight management program will be administered in addition to the subject's study medication assignment. The program includes internet counseling by an accredited health and fitness professional and a nutrition and exercise program with goal setting and educational and tracking tools.</description>
        </group>
        <group group_id="P2">
          <title>Placebo</title>
          <description>Administered in addition to the weight management program.
Weight Management Program: A comprehensive weight management program will be administered in addition to the subject's study medication assignment. The program includes internet counseling by an accredited health and fitness professional and a nutrition and exercise program with goal setting and educational and tracking tools.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="4456"/>
                <participants group_id="P2" count="4454"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Treated</title>
              <participants_list>
                <participants group_id="P1" count="4455"/>
                <participants group_id="P2" count="4450"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4455"/>
                <participants group_id="P2" count="4450"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Randomized but not dispensed study med</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>NB32</title>
          <description>NB32: Naltrexone SR 32 mg/Bupropion SR 360 mg/day. Administered in addition to the weight management program.
Weight Management Program: A comprehensive weight management program will be administered in addition to the subject's study medication assignment. The program includes internet counseling by an accredited health and fitness professional and a nutrition and exercise program with goal setting and educational and tracking tools.</description>
        </group>
        <group group_id="B2">
          <title>Placebo</title>
          <description>Administered in addition to the weight management program.
Weight Management Program: A comprehensive weight management program will be administered in addition to the subject's study medication assignment. The program includes internet counseling by an accredited health and fitness professional and a nutrition and exercise program with goal setting and educational and tracking tools.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="4455"/>
            <count group_id="B2" value="4450"/>
            <count group_id="B3" value="8905"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="4455"/>
                    <count group_id="B2" value="4450"/>
                    <count group_id="B3" value="8905"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2973"/>
                    <measurement group_id="B2" value="3053"/>
                    <measurement group_id="B3" value="6026"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1482"/>
                    <measurement group_id="B2" value="1397"/>
                    <measurement group_id="B3" value="2879"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="4455"/>
                    <count group_id="B2" value="4450"/>
                    <count group_id="B3" value="8905"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="61.1" spread="7.27"/>
                    <measurement group_id="B2" value="60.9" spread="7.38"/>
                    <measurement group_id="B3" value="61.0" spread="7.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="4455"/>
                    <count group_id="B2" value="4450"/>
                    <count group_id="B3" value="8905"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2437"/>
                    <measurement group_id="B2" value="2419"/>
                    <measurement group_id="B3" value="4856"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2018"/>
                    <measurement group_id="B2" value="2031"/>
                    <measurement group_id="B3" value="4049"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="4455"/>
                    <count group_id="B2" value="4450"/>
                    <count group_id="B3" value="8905"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="279"/>
                    <measurement group_id="B2" value="291"/>
                    <measurement group_id="B3" value="570"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4174"/>
                    <measurement group_id="B2" value="4156"/>
                    <measurement group_id="B3" value="8330"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="4455"/>
                    <count group_id="B2" value="4450"/>
                    <count group_id="B3" value="8905"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="31"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="46"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="656"/>
                    <measurement group_id="B2" value="648"/>
                    <measurement group_id="B3" value="1304"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3738"/>
                    <measurement group_id="B2" value="3698"/>
                    <measurement group_id="B3" value="7436"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="NA">Selection of multiple race categories was not permissible by the participants. Participants advised to select the most appropriate category.</measurement>
                    <measurement group_id="B2" value="NA">Selection of multiple race categories was not permissible by the participants. Participants advised to select the most appropriate category.</measurement>
                    <measurement group_id="B3" value="NA">Total not calculated because data are not available (NA) in one or more arms.</measurement>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="51"/>
                    <measurement group_id="B3" value="76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="4455"/>
                    <count group_id="B2" value="4450"/>
                    <count group_id="B3" value="8905"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4455"/>
                    <measurement group_id="B2" value="4450"/>
                    <measurement group_id="B3" value="8905"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight</title>
          <units>kilogram</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="4455"/>
                    <count group_id="B2" value="4450"/>
                    <count group_id="B3" value="8905"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="105.6" spread="19.09"/>
                    <measurement group_id="B2" value="106.3" spread="19.18"/>
                    <measurement group_id="B3" value="106.0" spread="19.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index (BMI)</title>
          <population>BMI was calculated at the site. Data are missing for 3 participants for whom the site did not calculate BMI, although weight and height were measured.</population>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="4452"/>
                    <count group_id="B2" value="4450"/>
                    <count group_id="B3" value="8902"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37.2" spread="5.26"/>
                    <measurement group_id="B2" value="37.4" spread="5.44"/>
                    <measurement group_id="B3" value="37.3" spread="5.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Cardiovascular (CV) risk group</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>CV disease without T2DM (type 2 diabetes mellitus)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="4455"/>
                    <count group_id="B2" value="4450"/>
                    <count group_id="B3" value="8905"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="670"/>
                    <measurement group_id="B2" value="646"/>
                    <measurement group_id="B3" value="1316"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CV disease with T2DM</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="4455"/>
                    <count group_id="B2" value="4450"/>
                    <count group_id="B3" value="8905"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="745"/>
                    <measurement group_id="B2" value="801"/>
                    <measurement group_id="B3" value="1546"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>T2DM without CV disease</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="4455"/>
                    <count group_id="B2" value="4450"/>
                    <count group_id="B3" value="8905"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3039"/>
                    <measurement group_id="B2" value="3002"/>
                    <measurement group_id="B3" value="6041"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Hypertension</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Yes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="4455"/>
                    <count group_id="B2" value="4450"/>
                    <count group_id="B3" value="8905"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4162"/>
                    <measurement group_id="B2" value="4117"/>
                    <measurement group_id="B3" value="8279"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="4455"/>
                    <count group_id="B2" value="4450"/>
                    <count group_id="B3" value="8905"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="293"/>
                    <measurement group_id="B2" value="333"/>
                    <measurement group_id="B3" value="626"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Dyslipidemia</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Yes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="4455"/>
                    <count group_id="B2" value="4450"/>
                    <count group_id="B3" value="8905"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4100"/>
                    <measurement group_id="B2" value="4070"/>
                    <measurement group_id="B3" value="8170"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="4455"/>
                    <count group_id="B2" value="4450"/>
                    <count group_id="B3" value="8905"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="355"/>
                    <measurement group_id="B2" value="380"/>
                    <measurement group_id="B3" value="735"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>History of Depression</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Yes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="4455"/>
                    <count group_id="B2" value="4450"/>
                    <count group_id="B3" value="8905"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1031"/>
                    <measurement group_id="B2" value="995"/>
                    <measurement group_id="B3" value="2026"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="4455"/>
                    <count group_id="B2" value="4450"/>
                    <count group_id="B3" value="8905"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3424"/>
                    <measurement group_id="B2" value="3455"/>
                    <measurement group_id="B3" value="6879"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Baseline Antidepressant Medication Use</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="4455"/>
                    <count group_id="B2" value="4450"/>
                    <count group_id="B3" value="8905"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1042"/>
                    <measurement group_id="B2" value="1015"/>
                    <measurement group_id="B3" value="2057"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Participants With a Confirmed Occurrence of Major Adverse Cardiovascular Event (MACE)</title>
        <description>The primary endpoint is the time from randomization to the first confirmed occurrence of any event within the primary MACE composite (defined as cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke). Due to early termination of the study, pre-planned 50% interim analysis is considered the primary analysis for outcome measures. The pre-planned 50% interim analysis was conducted when 50% of the total planned MACE were observed.</description>
        <time_frame>Confirmed occurrence of event between Day 1 (randomization) and up to a maximum of 4 years of follow-up</time_frame>
        <population>Intent-to-treat (ITT) population is defined as subjects who undergo randomization into the Treatment Period (TP) and are dispensed study medication. Treatment refers to the treatment assigned during TP randomization rather than the actual treatment received. ITT population is the primary analysis population for the primary and secondary endpoints.</population>
        <group_list>
          <group group_id="O1">
            <title>NB32</title>
            <description>NB32: Naltrexone SR 32 mg/Bupropion SR 360 mg/day. Administered in addition to the weight management program.
Weight Management Program: A comprehensive weight management program will be administered in addition to the subject's study medication assignment. The program includes internet counseling by an accredited health and fitness professional and a nutrition and exercise program with goal setting and educational and tracking tools.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Administered in addition to the weight management program.
Weight Management Program: A comprehensive weight management program will be administered in addition to the subject's study medication assignment. The program includes internet counseling by an accredited health and fitness professional and a nutrition and exercise program with goal setting and educational and tracking tools.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With a Confirmed Occurrence of Major Adverse Cardiovascular Event (MACE)</title>
          <description>The primary endpoint is the time from randomization to the first confirmed occurrence of any event within the primary MACE composite (defined as cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke). Due to early termination of the study, pre-planned 50% interim analysis is considered the primary analysis for outcome measures. The pre-planned 50% interim analysis was conducted when 50% of the total planned MACE were observed.</description>
          <population>Intent-to-treat (ITT) population is defined as subjects who undergo randomization into the Treatment Period (TP) and are dispensed study medication. Treatment refers to the treatment assigned during TP randomization rather than the actual treatment received. ITT population is the primary analysis population for the primary and secondary endpoints.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4455"/>
                <count group_id="O2" value="4450"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90"/>
                    <measurement group_id="O2" value="102"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>At the pre-planned 50% interim analysis, a non-inferiority analysis was conducted based on the estimated hazard ratio (NB32/Placebo) for the time to the first confirmed occurrence of MACE. The upper-bound of the 99.7% confidence interval for the hazard ratio was compared to 1.4, the non-inferiority margin.</non_inferiority_desc>
            <param_type>Cox Proportional Hazard</param_type>
            <param_value>0.88</param_value>
            <ci_percent>99.7</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.57</ci_lower_limit>
            <ci_upper_limit>1.34</ci_upper_limit>
            <estimate_desc>Hazard ratio is based on CPH model with treatment as a factor.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants With a Confirmed Occurrence of Cardiovascular Death, Nonfatal Myocardial Infarction, Nonfatal Stroke, or Nonfatal Unstable Angina Requiring Hospitalization</title>
        <description>Due to early termination of the study, the pre-planned 50% interim analysis is considered the primary analysis for outcome measures.</description>
        <time_frame>Confirmed occurrence of event between Day 1 (randomization) and up to a maximum of 4 years of follow-up</time_frame>
        <population>Intent-to-treat (ITT) population is defined as subjects who undergo randomization into the Treatment Period (TP) and are dispensed study medication. Treatment refers to the treatment assigned during TP randomization rather than the actual treatment received. ITT population is the primary analysis population for the primary and secondary endpoints.</population>
        <group_list>
          <group group_id="O1">
            <title>NB32</title>
            <description>NB32: Naltrexone SR 32 mg/Bupropion SR 360 mg/day. Administered in addition to the weight management program.
Weight Management Program: A comprehensive weight management program will be administered in addition to the subject's study medication assignment. The program includes internet counseling by an accredited health and fitness professional and a nutrition and exercise program with goal setting and educational and tracking tools.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Administered in addition to the weight management program.
Weight Management Program: A comprehensive weight management program will be administered in addition to the subject's study medication assignment. The program includes internet counseling by an accredited health and fitness professional and a nutrition and exercise program with goal setting and educational and tracking tools.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With a Confirmed Occurrence of Cardiovascular Death, Nonfatal Myocardial Infarction, Nonfatal Stroke, or Nonfatal Unstable Angina Requiring Hospitalization</title>
          <description>Due to early termination of the study, the pre-planned 50% interim analysis is considered the primary analysis for outcome measures.</description>
          <population>Intent-to-treat (ITT) population is defined as subjects who undergo randomization into the Treatment Period (TP) and are dispensed study medication. Treatment refers to the treatment assigned during TP randomization rather than the actual treatment received. ITT population is the primary analysis population for the primary and secondary endpoints.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4455"/>
                <count group_id="O2" value="4450"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="133"/>
                    <measurement group_id="O2" value="142"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Cox Proportional Hazard</param_type>
            <param_value>0.93</param_value>
            <ci_percent>99.7</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.66</ci_lower_limit>
            <ci_upper_limit>1.33</ci_upper_limit>
            <estimate_desc>Hazard ratio is based on CPH model with treatment as a factor.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants With a Confirmed Occurrence of Cardiovascular Death (Including Fatal Myocardial Infarction, Fatal Stroke)</title>
        <description>Due to early termination of the study, the pre-planned 50% interim analysis is considered the primary analysis for outcome measures.</description>
        <time_frame>Confirmed occurrence of event between Day 1 (randomization) and up to a maximum of 4 years of follow-up</time_frame>
        <population>Intent-to-treat (ITT) population is defined as subjects who undergo randomization into the Treatment Period (TP) and are dispensed study medication. Treatment refers to the treatment assigned during TP randomization rather than the actual treatment received. ITT population is the primary analysis population for the primary and secondary endpoints.</population>
        <group_list>
          <group group_id="O1">
            <title>NB32</title>
            <description>NB32: Naltrexone SR 32 mg/Bupropion SR 360 mg/day. Administered in addition to the weight management program.
Weight Management Program: A comprehensive weight management program will be administered in addition to the subject's study medication assignment. The program includes internet counseling by an accredited health and fitness professional and a nutrition and exercise program with goal setting and educational and tracking tools.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Administered in addition to the weight management program.
Weight Management Program: A comprehensive weight management program will be administered in addition to the subject's study medication assignment. The program includes internet counseling by an accredited health and fitness professional and a nutrition and exercise program with goal setting and educational and tracking tools.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With a Confirmed Occurrence of Cardiovascular Death (Including Fatal Myocardial Infarction, Fatal Stroke)</title>
          <description>Due to early termination of the study, the pre-planned 50% interim analysis is considered the primary analysis for outcome measures.</description>
          <population>Intent-to-treat (ITT) population is defined as subjects who undergo randomization into the Treatment Period (TP) and are dispensed study medication. Treatment refers to the treatment assigned during TP randomization rather than the actual treatment received. ITT population is the primary analysis population for the primary and secondary endpoints.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4455"/>
                <count group_id="O2" value="4450"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                    <measurement group_id="O2" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Cox Proportional Hazard</param_type>
            <param_value>0.50</param_value>
            <ci_percent>99.7</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.21</ci_lower_limit>
            <ci_upper_limit>1.19</ci_upper_limit>
            <estimate_desc>Hazard ratio is based on CPH model with treatment as a factor.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants With a Confirmed Occurrence of Myocardial Infarction (Nonfatal or Fatal)</title>
        <description>Due to early termination of the study, the pre-planned 50% interim analysis is considered the primary analysis for outcome measures.</description>
        <time_frame>Confirmed occurrence of event between Day 1 (randomization) and up to a maximum of 4 years of follow-up</time_frame>
        <population>Intent-to-treat (ITT) population is defined as subjects who undergo randomization into the Treatment Period (TP) and are dispensed study medication. Treatment refers to the treatment assigned during TP randomization rather than the actual treatment received. ITT population is the primary analysis population for the primary and secondary endpoints.</population>
        <group_list>
          <group group_id="O1">
            <title>NB32</title>
            <description>NB32: Naltrexone SR 32 mg/Bupropion SR 360 mg/day. Administered in addition to the weight management program.
Weight Management Program: A comprehensive weight management program will be administered in addition to the subject's study medication assignment. The program includes internet counseling by an accredited health and fitness professional and a nutrition and exercise program with goal setting and educational and tracking tools.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Administered in addition to the weight management program.
Weight Management Program: A comprehensive weight management program will be administered in addition to the subject's study medication assignment. The program includes internet counseling by an accredited health and fitness professional and a nutrition and exercise program with goal setting and educational and tracking tools.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With a Confirmed Occurrence of Myocardial Infarction (Nonfatal or Fatal)</title>
          <description>Due to early termination of the study, the pre-planned 50% interim analysis is considered the primary analysis for outcome measures.</description>
          <population>Intent-to-treat (ITT) population is defined as subjects who undergo randomization into the Treatment Period (TP) and are dispensed study medication. Treatment refers to the treatment assigned during TP randomization rather than the actual treatment received. ITT population is the primary analysis population for the primary and secondary endpoints.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4455"/>
                <count group_id="O2" value="4450"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55"/>
                    <measurement group_id="O2" value="57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Cox Proportional Hazard</param_type>
            <param_value>0.96</param_value>
            <ci_percent>99.7</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.55</ci_lower_limit>
            <ci_upper_limit>1.67</ci_upper_limit>
            <estimate_desc>Hazard ratio is based on CPH model with treatment as a factor.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants With a Confirmed Occurrence of Stroke (Nonfatal or Fatal)</title>
        <description>Due to early termination of the study, the pre-planned 50% interim analysis is considered the primary analysis for outcome measures.</description>
        <time_frame>Confirmed occurrence of event between Day 1 (randomization) and up to a maximum of 4 years of follow-up</time_frame>
        <population>Intent-to-treat (ITT) population is defined as subjects who undergo randomization into the Treatment Period (TP) and are dispensed study medication. Treatment refers to the treatment assigned during TP randomization rather than the actual treatment received. ITT population is the primary analysis population for the primary and secondary endpoints.</population>
        <group_list>
          <group group_id="O1">
            <title>NB32</title>
            <description>NB32: Naltrexone SR 32 mg/Bupropion SR 360 mg/day. Administered in addition to the weight management program.
Weight Management Program: A comprehensive weight management program will be administered in addition to the subject's study medication assignment. The program includes internet counseling by an accredited health and fitness professional and a nutrition and exercise program with goal setting and educational and tracking tools.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Administered in addition to the weight management program.
Weight Management Program: A comprehensive weight management program will be administered in addition to the subject's study medication assignment. The program includes internet counseling by an accredited health and fitness professional and a nutrition and exercise program with goal setting and educational and tracking tools.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With a Confirmed Occurrence of Stroke (Nonfatal or Fatal)</title>
          <description>Due to early termination of the study, the pre-planned 50% interim analysis is considered the primary analysis for outcome measures.</description>
          <population>Intent-to-treat (ITT) population is defined as subjects who undergo randomization into the Treatment Period (TP) and are dispensed study medication. Treatment refers to the treatment assigned during TP randomization rather than the actual treatment received. ITT population is the primary analysis population for the primary and secondary endpoints.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4455"/>
                <count group_id="O2" value="4450"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                    <measurement group_id="O2" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Cox Proportional Hazard</param_type>
            <param_value>1.04</param_value>
            <ci_percent>99.7</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.43</ci_lower_limit>
            <ci_upper_limit>2.55</ci_upper_limit>
            <estimate_desc>Hazard ratio is based on CPH model with treatment as a factor.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Treatment-emergent serious adverse events and treatment-emergent adverse events leading to study medication discontinuation are defined as those events with onset coincident with treatment period randomization starting at Visit 3 (Day 1) and through end of study or 30 days after discontinuation of study medication (whichever one is earlier).</time_frame>
      <desc>Safety data is based on all available data at the time of database lock, which occurred after the pre-planned 50% interim analysis.</desc>
      <group_list>
        <group group_id="E1">
          <title>NB32</title>
          <description>NB32: Naltrexone SR 32 mg/Bupropion SR 360 mg/day. Administered in addition to the weight management program.
Weight Management Program: A comprehensive weight management program will be administered in addition to the subject's study medication assignment. The program includes internet counseling by an accredited health and fitness professional and a nutrition and exercise program with goal setting and educational and tracking tools.</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>Administered in addition to the weight management program.
Weight Management Program: A comprehensive weight management program will be administered in addition to the subject's study medication assignment. The program includes internet counseling by an accredited health and fitness professional and a nutrition and exercise program with goal setting and educational and tracking tools.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 15.0</default_vocab>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="463" subjects_at_risk="4455"/>
                <counts group_id="E2" subjects_affected="386" subjects_at_risk="4450"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Haemorrhagic anaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Iron deficiency anaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Lymphadenopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Accelerated idioventricular rhythm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Acute coronary syndrome</sub_title>
                <counts group_id="E1" events="6" subjects_affected="4" subjects_at_risk="4455"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Acute myocardial infarction</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="4455"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" events="17" subjects_affected="17" subjects_at_risk="4455"/>
                <counts group_id="E2" events="15" subjects_affected="15" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Angina unstable</sub_title>
                <counts group_id="E1" events="25" subjects_affected="22" subjects_at_risk="4455"/>
                <counts group_id="E2" events="16" subjects_affected="15" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Aortic valve disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis coronary artery</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="4455"/>
                <counts group_id="E2" events="15" subjects_affected="15" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Atrial flutter</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Atrial tachycardia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Atrial thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Atrioventricular block</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Atrioventricular block complete</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Cardiac failure acute</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Cardiac failure congestive</sub_title>
                <counts group_id="E1" events="16" subjects_affected="13" subjects_at_risk="4455"/>
                <counts group_id="E2" events="11" subjects_affected="8" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Cardio-respiratory arrest</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Chronotropic incompetence</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Congestive cardiomyopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Coronary artery disease</sub_title>
                <counts group_id="E1" events="22" subjects_affected="21" subjects_at_risk="4455"/>
                <counts group_id="E2" events="21" subjects_affected="21" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Coronary artery occlusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Coronary artery stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Ischaemic cardiomyopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" events="14" subjects_affected="14" subjects_at_risk="4455"/>
                <counts group_id="E2" events="13" subjects_affected="13" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Myocardial ischaemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Palpitations</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Pericardial effusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Sick sinus syndrome</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Supraventricular tachycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Ventricular fibrillation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Ventricular tachycardia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Haemorrhagic arteriovenous malformation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Porphyria acute</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Adrenal insufficiency</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Goitre</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Hyperparathyroidism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal adhesions</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Abdominal hernia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Abdominal hernia obstructive</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Abdominal pain lower</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Abdominal strangulated hernia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Colitis ischaemic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Crohn's disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Diverticulum intestinal haemorrhagic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Duodenitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Enteritis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Gastric ulcer haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Gastrointestinal ulcer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Gastrointestinal ulcer haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Haematochezia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Hiatus hernia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Hiatus hernia, obstructive</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Impaired gastric emptying</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Inguinal hernia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Intestinal perforation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Large intestine polyp</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Lower gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Obstruction gastric</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Oesophageal spasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Oesophagitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Oesophagitis haemorrhagic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4455"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Pancreatitis acute</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Peptic ulcer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Retroperitoneal haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Small intestinal obstruction</sub_title>
                <counts group_id="E1" events="10" subjects_affected="9" subjects_at_risk="4455"/>
                <counts group_id="E2" events="5" subjects_affected="3" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Umbilical hernia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Umbilical hernia, obstructive</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Upper gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Chest discomfort</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" events="15" subjects_affected="15" subjects_at_risk="4455"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Cyst</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Device dislocation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Device malfunction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Fat tissue increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Ischaemic ulcer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" events="22" subjects_affected="22" subjects_at_risk="4455"/>
                <counts group_id="E2" events="13" subjects_affected="13" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Sudden cardiac death</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Surgical failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Systemic inflammatory response syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Unevaluable event</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Bile duct stone</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Biliary colic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Biliary dyskinesia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Cholecystitis acute</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4455"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Cholecystitis chronic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Drug-induced liver injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Gallbladder disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Gallbladder polyp</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Hepatic cyst</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaphylactic reaction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Hypersensitivity</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abdominal wall abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Abscess limb</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Appendicitis perforated</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Arthritis bacterial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Bursitis infective staphylococcal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" events="17" subjects_affected="16" subjects_at_risk="4455"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Cellulitis of male external genital organ</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Cellulitis staphylococcal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Clostridium difficile colitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Clostridium difficile infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Colonic abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4455"/>
                <counts group_id="E2" events="7" subjects_affected="6" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Escherichia bacteraemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" events="5" subjects_affected="3" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Gastroenteritis bacterial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Gastroenteritis viral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Human ehrlichiosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Infected bites</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Intervertebral discitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Lobar pneumonia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Lung infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Osteomyelitis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Perirectal abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Pharyngeal abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="13" subjects_affected="12" subjects_at_risk="4455"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Pneumonia staphylococcal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Septic shock</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Staphylococcal infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Urinary tract infection bacterial</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Urosepsis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Wound abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Acetabulum fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Ankle fracture</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="4455"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Cervical vertebral fracture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Concussion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Craniocerebral injury</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Cystitis radiation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Femoral neck fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Femur fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Gastrointestinal stoma complication</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Gun shot wound</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Head injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Hip fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Humerus fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Incisional hernia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Joint dislocation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Joint injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Lower limb fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Meniscus injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Multiple injuries</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Postoperative ileus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Postoperative respiratory failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Procedural pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Radius fracture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Rib fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Road traffic accident</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Skull fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Spinal column injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Spinal cord injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Spinal fracture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Subdural haematoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Tendon rupture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Thermal burn</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Ulna fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Upper limb fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Wound dehiscence</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Wrist fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Anticoagulation drug level below therapeutic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Blood potassium decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Blood potassium increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Blood pressure increased</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Thyroid function test abnormal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Troponin increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Alkalosis hypochloraemic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus inadequate control</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Fluid overload</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Metabolic acidosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Obesity</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="4450"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Bursitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Cervical spinal stenosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Exostosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Intervertebral disc compression</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Intervertebral disc degeneration</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Intervertebral disc disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Intervertebral disc protrusion</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Lumbar spinal stenosis</sub_title>
                <counts group_id="E1" events="9" subjects_affected="8" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Neck pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" events="42" subjects_affected="40" subjects_at_risk="4455"/>
                <counts group_id="E2" events="44" subjects_affected="41" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Osteoarthropathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Osteonecrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Resorption bone increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Rheumatoid arthritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Rotator cuff syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Spinal column stenosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Spinal ligament ossification</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Spinal osteoarthritis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Spondylolisthesis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Synovial cyst</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Vertebral osteophyte</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Acute myeloid leukaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma gastric</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma pancreas</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Adenoma benign</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>B-cell lymphoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>B-cell unclassifiable lymphoma high grade</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Basal cell carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Benign lung neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Bladder cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Bladder transitional cell carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Bowen's disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Breast cancer</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="4455"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Cholangiocarcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Clear cell renal cell carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Colon adenoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Colon cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Colon cancer metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Endometrial adenocarcinoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Endometrial cancer</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Glioblastoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Glioblastoma multiforme</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Invasive ductal breast carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Leukaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Lung neoplasm malignant</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Malignant melanoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Malignant melanoma in situ</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Mesothelioma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Metastases to liver</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Metastases to spleen</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Metastatic neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Metastatic squamous cell carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Non-Hodgkin's lymphoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Oesophageal adenocarcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Oesophageal cancer metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Ovarian cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Ovarian granulosa cell tumour</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Phaeochromocytoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Prostate cancer</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4455"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Prostate cancer stage II</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Renal cancer</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Renal cell carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of skin</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Thymoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Thyroid neoplasm</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Tongue neoplasm malignant stage unspecified</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Tonsil cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Uterine cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Uterine leiomyoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4450"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Aphasia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Brain stem stroke</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Carotid artery disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Carotid artery occlusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Carotid artery stenosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Cerebellar haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Cerebral infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="4455"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Complicated migraine</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Convulsion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Dementia with Lewy bodies</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Diabetic hyperosmolar coma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Encephalopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Haemorrhage intracranial</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Hemiparesis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Hydrocephalus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Ischaemic stroke</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Lacunar infarction</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Lumbar radiculopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Metabolic encephalopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Nerve root compression</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Normal pressure hydrocephalus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Presyncope</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Spondylitic myelopathy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Subarachnoid haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="4455"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Transient ischaemic attack</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>VIIth nerve paralysis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Alcohol withdrawal syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Bipolar disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Delirium</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Hallucination</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Major depression</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Mental status changes</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Suicidal ideation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Acute prerenal failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Nephrosclerosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Obstructive uropathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Renal failure acute</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="4455"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Renal failure chronic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Urinary retention</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Benign prostatic hyperplasia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Cystocele</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Endometrial hyperplasia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Ovarian mass</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Pelvic prolapse</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Rectocele</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Uterine prolapse</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Uterovaginal prolapse</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute pulmonary oedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Acute respiratory failure</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Bronchospasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" events="10" subjects_affected="6" subjects_at_risk="4455"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Dyspnoea exertional</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Pleurisy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Pleuritic pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="7" subjects_affected="6" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Pulmonary haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Pulmonary hypertension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Pulmonary thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Respiratory distress</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Angioedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Skin ulcer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Subcutaneous emphysema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Gastrectomy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Hip surgery</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Accelerated hypertension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Aortic aneurysm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Aortic stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Arterial occlusive disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Hypertensive crisis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Iliac artery occlusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Orthostatic hypotension</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Peripheral artery thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Peripheral ischaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Peripheral vascular disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Subclavian artery stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>MedDRA 15.0</default_vocab>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1157" subjects_at_risk="4455"/>
                <counts group_id="E2" subjects_affected="282" subjects_at_risk="4450"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Cardiac discomfort</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Cardiac failure congestive</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Cardiac flutter</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Extrasystoles</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Palpitations</sub_title>
                <counts group_id="E1" events="20" subjects_affected="20" subjects_at_risk="4455"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Hearing impaired</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Tinnitus</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Vertigo positional</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Blepharospasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Diplopia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Vision blurred</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Visual acuity reduced</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal discomfort</sub_title>
                <counts group_id="E1" events="27" subjects_affected="27" subjects_at_risk="4455"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Abdominal distension</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" events="18" subjects_affected="18" subjects_at_risk="4455"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Abdominal pain lower</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" events="18" subjects_affected="18" subjects_at_risk="4455"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Bowel movement irregularity</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Coeliac disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" events="129" subjects_affected="129" subjects_at_risk="4455"/>
                <counts group_id="E2" events="15" subjects_affected="15" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" events="35" subjects_affected="35" subjects_at_risk="4455"/>
                <counts group_id="E2" events="21" subjects_affected="21" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Diverticulum</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Dry mouth</sub_title>
                <counts group_id="E1" events="21" subjects_affected="21" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Epigastric discomfort</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Eructation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Faecal incontinence</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Flatulence</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Frequent bowel movements</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Gastrointestinal hypermotility</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="4455"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Haematemesis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Haematochezia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Haemorrhoids</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia oral</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Intestinal obstruction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Irritable bowel syndrome</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Lip swelling</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="346" subjects_affected="346" subjects_at_risk="4455"/>
                <counts group_id="E2" events="21" subjects_affected="21" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Oesophageal rupture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Retching</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Stomatitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Upper gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="89" subjects_affected="89" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Vomiting projectile</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Chest discomfort</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Drug intolerance</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Feeling abnormal</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Feeling cold</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Feeling jittery</sub_title>
                <counts group_id="E1" events="16" subjects_affected="16" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Feeling of body temperature change</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Gait disturbance</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Generalised oedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Influenza like illness</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Local swelling</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Mucosal dryness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Hepatic cirrhosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Drug hypersensitivity</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Hypersensitivity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Acute sinusitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Bronchopneumonia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Helicobacter infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Impetigo</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Pharyngitis streptococcal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Viral infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Ankle fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Foot fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Humerus fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Joint injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Ligament rupture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Lower limb fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Meniscus injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Muscle injury</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Muscle strain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Procedural pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Rib fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Tendon injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Tendon rupture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Upper limb fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Alanine aminotransferase increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Aspartate aminotransferase increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Blood creatinine increased</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Blood glucose decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Blood glucose increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Blood pressure increased</sub_title>
                <counts group_id="E1" events="20" subjects_affected="20" subjects_at_risk="4455"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Blood pressure systolic increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Grip strength decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Heart rate increased</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Hepatic enzyme increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>International normalised ratio increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Prostatic specific antigen increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Weight increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Decreased appetite</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Gout</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Hyperphagia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Increased appetite</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="4455"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4455"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Intervertebral disc degeneration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Intervertebral disc protrusion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Muscle spasms</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Muscle twitching</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Muscular weakness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Musculoskeletal stiffness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Neck pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Osteoporosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4455"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Polymyalgia rheumatica</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Rotator cuff syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="4450"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Benign breast neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Breast cancer</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Malignant melanoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Altered state of consciousness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Amnesia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4455"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Balance disorder</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Burning sensation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Carpal tunnel syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Disturbance in attention</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="67" subjects_affected="64" subjects_at_risk="4455"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Dizziness postural</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Dysgeusia</sub_title>
                <counts group_id="E1" events="16" subjects_affected="16" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Dysgraphia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Dyskinesia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Essential tremor</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="51" subjects_affected="51" subjects_at_risk="4455"/>
                <counts group_id="E2" events="15" subjects_affected="15" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Lethargy</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Memory impairment</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4455"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Migraine</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Multiple sclerosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Muscle contractions involuntary</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Nerve compression</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Neurodegenerative disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Parkinson's disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Restless legs syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Sciatica</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Somnolence</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Spinal meningeal cyst</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Tremor</sub_title>
                <counts group_id="E1" events="81" subjects_affected="80" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>VIIth nerve paralysis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Abnormal behaviour</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Abnormal dreams</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Affect lability</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4455"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Agitation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Anger</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" events="26" subjects_affected="26" subjects_at_risk="4455"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Apathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Aversion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Bruxism</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Confusional state</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="4455"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Disorientation</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Fear</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Hallucination</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Hallucination, auditory</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Hallucination, visual</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" events="38" subjects_affected="38" subjects_at_risk="4455"/>
                <counts group_id="E2" events="16" subjects_affected="16" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Irritability</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Libido decreased</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Major depression</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Mental disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Middle insomnia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Mood altered</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Mood swings</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Nervousness</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Nightmare</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Obsessive-compulsive disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Panic attack</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Paranoia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Personality change</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Psychomotor retardation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Restlessness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Sleep disorder</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Sleep talking</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Sleep terror</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Suicidal ideation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Dysuria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Glomerulosclerosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Pollakiuria</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Renal colic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Renal failure chronic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Renal impairment</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Urinary hesitation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Benign prostatic hyperplasia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Ejaculation disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Erectile dysfunction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Vaginal prolapse</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Choking sensation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Dysphonia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Dyspnoea exertional</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Nasal discomfort</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Oropharyngeal pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Paranasal sinus hypersecretion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Pleurisy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Pulmonary fibrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Sinus congestion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Wheezing</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Alopecia</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="4455"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Angioedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Dermatitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Dermatitis contact</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Drug eruption</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Hyperhidrosis</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Night sweats</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Pruritus</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="4455"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Pruritus generalised</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="4455"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Skin irritation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Skin reaction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Swelling face</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Urticaria</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="4455"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="4450"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Cardioversion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Knee arthroplasty</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Flushing</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Hot flush</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="4455"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="25" subjects_affected="25" subjects_at_risk="4455"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4455"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4450"/>
              </event>
              <event>
                <sub_title>Labile blood pressure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4455"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4450"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>If not already published by Sponsor as part of a multi-center publication, 24 months after conclusion, abandonment or termination of the study or notification that there will be no such multi-center publication, PI may publish the results for PI's study center individually. Prior to such publication, PI must provide Sponsor with at least 90 days to review and comment on the proposed publication. Sponsor may delay publication for up to an additional 6-month period to file for patent protection.</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>The study was terminated early. Outcome measures data is based on the 50% interim analysis, designated as the primary analysis. Safety data is based on all available data at the time of database lock, which occurred after the 50% interim analysis.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Global Head of Development</name_or_title>
      <organization>Orexigen Therapeutics, Inc.</organization>
      <phone>858-875-8600</phone>
      <email>MedInfo@Orexigen.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

